Akorn-Strides jv enters buy agreement with Pfizer for ANDAs Akorn.

For its portion, Akorn, Inc. Will receive $35 million in money. Until April 30 Akorn-Strides LLC will continue steadily to produce and distribute the accepted products, 2011. September 30 In the three quarters finished, 2010, Akorn recognized $1.9 million in revenue and around $2.0 million in altered EBITDA as a total result of its participation in the Akorn-Strides LLC joint venture. Raj Rai, CEO, commented, This is a positive outcome for Akorn as the proceeds from the sale provide us with immediate usage of capital to accelerate our infrastructure improvements, pursue acquisitions and in-licensing of specific niche market pharmaceuticals, and also our balance sheet strengthen. We wish to thank our joint venture partner, Strides, for assisting build value in our joint venture which includes led to a mutually helpful strategic outcome.This conference offers a forum for experts in the field of aging to provide their work and talk about ideas about gerontological and geriatric education and training. Complete meeting details can be found at Mass media representatives are invited to wait free of charge. Opening Plenary Program: Thursday, March 4, 6:30 p.m. Eldercare Workforce Problem: Our Call to Arms John W. Rowe, MD, will contact the audience’s focus on the looming crisis in the product quality and organization of the heath care workforce for tomorrow’s old adults. He is the co-writer of the broadly acclaimed book Effective Aging; and seat of the Institute of Medicine study group that produced the report Retooling for an Aging America: Building medical Treatment Workforce.